Ac Immune Advances Anti-Tau Vaccine ACI-35.030 pour la phase 2 de l'essai.

Published Date: 24 Dec 2023

500 people with preclinical Alzheimer's disease will be randomized to either ACI-35.030 or a placebo for a maximum of four years in the recently announced trial, called ReTain.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot